Volume 14, Number 11—November 2008
CME ACTIVITY - Research
Antimicrobial Drug Use and Resistance in Europe
Table 4
Models | Outcome variable: logodds PNSP |
|||
---|---|---|---|---|
Exposure | Parameter estimate | p value | R2 | |
Model 1 | ||||
Intercept | –4.75 | |||
Gradient | Penicillins | 0.29 | 0.0002 | 0.61 |
Model 2 | ||||
Intercept | –4.8 | |||
Gradient | Penicillins | 0.33 | 0.002 | |
Other β-lactams | –0.05 | 0.808 | ||
Fluoroquinolones |
–0.11 |
0.73 |
0.62 |
|
Outcome variable: logodds ENSP |
||||
Model 1 | ||||
Intercept | –2.82 | |||
Gradient | Other β-lactams | 0.41 | 0.003 | 0.48 |
Model 2 | ||||
Intercept | –3.26 | |||
Gradient | Other β-lactams | 0.25 | 0.14 | |
MLS class | 0.15 | 0.39 | ||
Fluoroquinolones | 0.30 | 0.35 | 0.56 |
*PNSP, penicillin-nonsusceptible Streptococcus pneumoniae; ENSP, erythromycin-nonsusceptible S. pneumoniae; MLS, macrolides, lincosamines, and streptogramins.
1National representatives of these 2 project groups in 2005 were as follows: Austria: H. Mittermayer, S. Metz, W. Koller (European Antimicrobial Resistance Surveillance System [EARSS]); Belgium: E. Hendrickx (EARSS), H. Goossens; Bulgaria: B. Markova; Croatia: A. Tambic-Andrasevic, Igor Francetic (European Surveillance of Antimicrobial Consumption [ESAC]), S. Kalenic (EARSS); Cyprus: D. Bagatzouni (EARSS); Czech Republic: P. Dvorak (ESAC), P. Urbaskova (EARSS); Denmark: D. Monnet, A. Anker Nielsen (ESAC); Estonia: P. Naaber (EARSS); Finland: P. Huovinen (ESAC), P. Paakkari (ESAC), O. Lyytikainen (EARSS), A. Nissinen (EARSS); France: P. Maugendre (ESAC), D. Guillemot (ESAC), B. Coignard, (EARSS), V. Jarlier (EARSS); Germany: W. Kern (ESAC), H. Schroeder (ESAC), W. Witte (EARSS), K. Heckenbach (EARSS); Greece: H. Giamarellou (ESAC), A. Antoniadou (ESAC), A. Tsakris (EARSS), A. Vatopoulos (EARSS); Hungary: G. Ternak (ESAC), M. Fuzi (EARSS); Iceland: K. Kristinsson; Ireland: E. Smyth (ESAC), R. Cunney (ESAC), D. Igoe (EARSS), O. Murphy (EARSS); Israel: R. Raz (EARSS); Italy: G. Cornaglia, A. Pantosti (EARSS), P. D’Ancona (EARSS); Latvia: S. Berzina (ESAC), A. Balode (EARSS); Lithuania: R. Valenteliene (ESAC), J. Miciulevicience; Luxembourg: R. Hemmer, M. Bruch (ESAC); Malta: M. Borg, P. Zarb (ESAC); the Netherlands: R. Janknegt (ESAC), M. Filius (ESAC), H. de Neeling (EARSS), E. Tiemermsa, J Degener (EARSS); Norway: H. Salvesen Blix (ESAC), A. Hoiby (EARSS), G. Simonsen (EARSS); Poland: W. Hryniewicz, P. Grzesiowski; Portugal: L. Caldeira (ESAC), M. Canica (EARSS); Romania: I. Codita; Slovakia: V. Foltan (ESAC), T. Tesar (ESAC), L. Langsadl (EARSS); Slovenia: M. Cizman (ESAC), M. Mueller-Premru (EARSS), J. Kolman (EARSS); Spain: J. Campos, F. Baquero (EARSS); Sweden: O. Cars (ESAC), G. Skoog (ESAC), B. Liljequist (EARSS), G. Kahlmeter (EARSS); Turkey: S. Unal (ESAC), D. Gür (EARSS); United Kingdom: P. Davey (ESAC), A. Johnson (EARSS), R. Hill (EARSS), H. Hughes (EARSS), M. Coyne (EARSS).